12-50086327-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2
The NM_003076.5(SMARCD1):c.344C>T(p.Ala115Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,368,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003076.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000140 AC: 2AN: 142738Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000128 AC: 3AN: 234978Hom.: 0 AF XY: 0.00000786 AC XY: 1AN XY: 127268
GnomAD4 exome AF: 0.0000163 AC: 20AN: 1226058Hom.: 0 Cov.: 33 AF XY: 0.0000165 AC XY: 10AN XY: 606914
GnomAD4 genome AF: 0.0000140 AC: 2AN: 142738Hom.: 0 Cov.: 31 AF XY: 0.0000288 AC XY: 2AN XY: 69376
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2022 | The c.344C>T (p.A115V) alteration is located in exon 2 (coding exon 2) of the SMARCD1 gene. This alteration results from a C to T substitution at nucleotide position 344, causing the alanine (A) at amino acid position 115 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at